News
Two of AcouSort’s board members and CEO acquire shares
AcouSort AB (publ) (“AcouSort” or the “Company”) today announces that founders and board members Thomas Laurell and Stefan Scheding...
Read MoreThe BioWings project creates new opportunities for large-scale production and exosome-based diagnostics
AcouSort and its collaborators are now finishing the 4-year BioWings project which has developed new thin-film materials generating the...
Read MoreAcouSort presents at Stora Aktiedagen in Stockholm, November 30, addressing current developments in the vibrant cell therapy space
On November 30, 2022, CEO Torsten Freltoft will present at Stora Aktiedagen in Stockholm. In his presentation, Torsten will...
Read MoreTwo of AcouSort’s board members and CEO acquire shares
AcouSort AB (publ) (“AcouSort” or the “Company”) today announces that founders and board members Thomas Laurell and Stefan Scheding...
Read MoreThe BioWings project creates new opportunities for large-scale production and exosome-based diagnostics
AcouSort and its collaborators are now finishing the 4-year BioWings project which has developed new thin-film materials generating the...
Read MoreAcouSort presents at Stora Aktiedagen in Stockholm, November 30, addressing current developments in the vibrant cell therapy space
On November 30, 2022, CEO Torsten Freltoft will present at Stora Aktiedagen in Stockholm. In his presentation, Torsten will...
Read MoreAcouSort featured in Investerarbrevet and Stockpicker
AcouSort is featured in a new article at Swedish investor sites Stockpicker and Investerarbrevet. The article “AcouSort går från...
Read MoreInterview with CEO
“The market for consumable and semi-consumable blood-plasma separation modules is estimated to grow significantly in the coming years as...
Read MoreAcouSort’s technology can streamline health care – rapidly increasing global interest
AcouSort’s technology uses soundwaves to separate cells and other particles in biological fluids, for example blood samples. The technology...
Read More